FDAHealthJanuary 29, 2026

Teva Pharmaceuticals USA, Inc — Metoprolol Succinate Extended-Release Tablets, 25 mg, 100 tablets bottles (NDC: 45963-709-11) and 1,000 tablets bottles (NDC: 45963-709-96), Rx Only, Teva Pharmaceutica

⚠️ Failed Dissolution Specifications

Is this relevant to me?

Geography: Nationwide
Source agency: FDA
Category: Health
Published: January 29, 2026

Nationwide

What's affected?

Product: Metoprolol Succinate Extended-Release Tablets, 25 mg, 100 tablets bottles (NDC: 45963-709-11) and 1,000 tablets bottles (NDC: 45963-709-96), Rx Only, Teva Pharmaceuticals, Parsippany, NJ 07054
Brand: METOPROLOL SUCCINATE
Lot code: a)

Additional details

Lot#: a) 0715J251, Exp.: 12/2026; 0716J251, Exp.: 01/2027; 0717J251, Exp.: 01/2027; b) 0715J252, Exp.: 12/2026; 0716J252, Exp.: 01/2027, 0717J252, Exp.: 01/2027.

What should I do?

Recommended action

Class II recall. Voluntary: Firm initiated Quantity affected: 18,780 bottles.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.